PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Investigating the link between Parkinson's and pesticides

2013-12-04
(Press-News.org) Contact information: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Investigating the link between Parkinson's and pesticides In a seemingly simple experiment, a scientist exposes rats to a certain pesticide over several days, and the rodents start showing symptoms remarkably similar to those seen in Parkinson's patients. But the scientific search for the causes of the disease, which affects 7 million to 10 million people worldwide, is nowhere near simple. An article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society, dives into the potential pesticide-Parkinson's link.

Lauren K. Wolf, associate editor at C&EN, explains that the focus on pesticides as a potential culprit for inducing Parkinson's can be traced back 30 years to an unexpected origin, the illicit drug market. In 1982, a handful of young people showed up at medical centers with symptoms of the disease. It turns out that chemistry-savvy criminals had been experimenting with a new designer, heroine-like drug containing a compound that breaks down into a powerful neurotoxin. And these patients had taken the drug. Researchers found out the compound's neurotoxic derivative had also been developed as an herbicide in the 1970s. That was the tip-off. The article notes that 30 years on, the evidence supporting a link between pesticides and Parkinson's is mounting. At the same time, many people exposed to pesticides don't develop the disease. Scientists are looking for the specific pesticides involved and for possible genetic explanations of what makes some people more susceptible than others. They have found at least two genetic mutations that can increase a pesticide-exposed person's risk for Parkinson's, discoveries that are leading to the next stage in their search to understand a complicated disease.

### The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 163,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.

Follow us: Twitter Facebook END


ELSE PRESS RELEASES FROM THIS DATE:

Carnegie Mellon scheme uses shared visual cues to help people remember multiple passwords

2013-12-04
Carnegie Mellon scheme uses shared visual cues to help people remember multiple passwords New approach strikes balance between password security and usability PITTSBURGH—It turns out that the way to keep track of your many passwords to online accounts is the same ...

Can iPads help students learn science? Yes.

2013-12-04
Can iPads help students learn science? Yes. The scale of the universe can be difficult to comprehend. Pretend you are going to make a scale model with a basketball representing the Earth and a tennis ball as the Moon. How far would you ...

Multiple mates worth the risk for female prairie dogs

2013-12-04
Multiple mates worth the risk for female prairie dogs FROSTBURG, MD (December 4, 2013) –Mating with more than one male increases reproductive success for female prairie dogs, despite an increase in risks. This is according to ...

Mysteries of Earth's radiation belts uncovered by NASA twin spacecraft

2013-12-04
Mysteries of Earth's radiation belts uncovered by NASA twin spacecraft DURHAM, N.H. -- Just over a year since launch, NASA's Van Allen Probes mission continues to unravel longstanding mysteries of Earth's high-energy radiation belts that encircle our planet and ...

Data on people's self-reported 'experienced' well-being could help inform policies

2013-12-04
Data on people's self-reported 'experienced' well-being could help inform policies WASHINGTON -- Gathering survey data on "experienced" well-being – the self-reported levels of contentment, joy, stress, frustration, and other feelings people experience throughout ...

CU-Boulder-led team finds first evidence of primates regularly sleeping in caves

2013-12-04
CU-Boulder-led team finds first evidence of primates regularly sleeping in caves Scientists have discovered that some ring-tailed lemurs in Madagascar regularly retire to limestone chambers for their nightly snoozes, the first evidence of the consistent, ...

Study finds that carbon monoxide can help shrink tumors and amplify effectiveness of chemotherapy

2013-12-04
Study finds that carbon monoxide can help shrink tumors and amplify effectiveness of chemotherapy Therapeutic benefits appear linked to cell's energy status; used in combination with chemo, CO helps spare healthy tissue BOSTON -- In recent years, ...

The first decade: Team reports on US trials of bioenergy grasses

2013-12-04
The first decade: Team reports on US trials of bioenergy grasses CHAMPAIGN, Ill. — The first long-term U.S. field trials of Miscanthus x giganteus, a towering perennial grass used in bioenergy production, reveal ...

AGU journal highlights -- Dec. 4, 2013

2013-12-04
AGU journal highlights -- Dec. 4, 2013 The following highlights summarize research papers that have been recently published in Geochemistry, Geophysics, Geosystems (G3), Geophysical Research Letters (GRL), and Journal of Geophysical Research-Atmospheres (JGR-D). In ...

Death of an adult son increases depressive symptoms in mothers, but not fathers

2013-12-04
Death of an adult son increases depressive symptoms in mothers, but not fathers PRINCETON, NJ—Mothers – but not fathers – exhibited symptoms of depression and experienced declines in overall health after ...

LAST 30 PRESS RELEASES:

New study and major data updates expand the Kids First data ecosystem

Seaweed snare: Sargassum stops sea turtle hatchlings in their tracks

Scientists uncover key to decoupling economic growth from pollution in developing countries

Frailty fuels gut imbalance and post-surgery gastrointestinal risks

BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

Phase III trial finds hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedule in LS-SCLC

Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds

Video assisted thoracoscopy surgery reduces mortality by 21 percent compared to lobectomy

NADIM ADJUVANT trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC

EA5181 phase 3 trial finds no OS benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable stage 3 NSCLC

Training to improve memory

Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

[Press-News.org] Investigating the link between Parkinson's and pesticides